FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefepime Injection
Status: Currently in Shortage
»Date first posted: 07/22/2015
»Therapeutic Categories: Anti-Infective; Pediatric

Expand all

Apotex Corp. (New 01/11/2018)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cefepime for Injection 1 g (10 vials) (NDC 60505-6146-04) Available
Cefepime for Injection 1 g (1 vial) (NDC 60505-6146-00) Available
Cefepime for Injection 2 g (10 vials) (NDC 60505-6147-04) Available
Cefepime for Injection 2 g (1 vial) (NDC 60505-6147-00) Available
Cefepime for Injection 1 g (1 vial) (NDC 60505-0834-00) Available

B. Braun Medical Inc. (Reverified 11/02/2017)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cefepime 1 g (NDC 0264-3193-11) On allocation to contract customers only due to increase in product demand. No interruption in supply. Demand increase for the drug
Cefepime 2 g (NDC 0264-3195-11) Available. No interruption in supply. Demand increase for the drug

Baxter Healthcare (Reverified 10/25/2017)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cefepime Injection, 1 gram/50mL, GALAXY Container (NDC 0338-1301-41) Available Other
Cefepime Injection, 2 gram/100mL, GALAXY Container (NDC 0338-1301-48) Available Other

Fresenius Kabi USA, LLC (Reverified 02/15/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g single dose vial, sterile powder (NDC 63323-326-20) Available Check wholesalers for inventory Demand increase for the drug
2 g single dose vial, sterile powder (NDC 63323-340-20) Available Check wholesalers for inventory Demand increase for the drug

Hospira, Inc. (Revised 02/14/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2g Single Dose ADD-Vantage™ Glass Vial (NDC 0409-0218-01) Next delivery & Estimated recovery: March 2018 Check Wholesaler for Availability. Shortage per Manufacturer: Manufacturing Delay Other
1g Single Dose ADD-Vantage™ Glass Vial (NDC 0409-0217-01) Next delivery: Mid February 2018; Estimated recovery: June 2018 Check Wholesaler for Availability. Shortage per Manufacturer: Manufacturing Delay Other
1g Single Dose Glass Fliptop Vial (NDC 0409-0219-01) Available Available Other
2g Single Dose Glass Fliptop Vial (NDC 0409-0220-01) Available Available Other

Sagent Pharmaceuticals (Reverified 02/23/2018)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g vial (NDC 25021-121-20) Available Available
2 g vial (NDC 25021-122-50) Available Available

WG Critical Care (Reverified 01/22/2018)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g vial (NDC 44567-0240-10) Available Please check wholesalers and distributors for inventory. Demand increase for the drug
2 g vial (NDC 44567-0241-10) Available Please check wholesalers and distributors for inventory. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English